The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis
Turkish Journal of Medical Sciences · 10.12.2024 · 54 (6) · 1310-1318
DOI: 10.55730/1300-0144.5914 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 10.12.2024. Verfasst von Alper Doğanci und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkiye. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Spondylitis, Ankylosing, Adalimumab, Etanercept. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background and aim: We aimed to investigate the relationship between serum anti-drug antibody (ADAb), hypersensitivity reactions (HSRs) to anti-tumor necrosis factors (anti-TNFs) drugs and to detect the role of skin tests in the diagnosis of HSRs against anti-TNFs.Material and methods: 69 ankylosing spondilitis (AS) and 46 rheumatoid artritis (RA) patients using infliximab, adalimumab, and etanercept were enrolled. Disease activity scores for AS and RA patients were assessed. Serum levels of anti-TNFs and ADAb to these agents were measured with the ELISA.These blood samples were taken 24 hours before the next drug dose.The patients with anti-TNF-associated HSRs were evaluated with a skin prick test (SPT) and intradermal test (IDT). Readings for SPT and IDT were conducted after 15 min, 24, 48, and 72 hours. Heel diameter of 3 mm or more, greater than negative control was considered positive for SPT, and if the size of the initial wheal had increased by at least 3 mm in diameter and was surrounded by erythema was considered positive for IDT. Symptoms such as urticaria/angioedema, flushing, etc. were considered immediate type HSRs. Findings developed at the injection site such as swelling, erythema, etc were considered injection site reactions (ISRs). An overall p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, Sivas, Turkiye.
- Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Ankara University, Ankara, Turkiye.
- Division of Rheumatology, Department of Physical Medicine and Rehabilitation, Ankara Liv Hospital, Ankara, Turkiye.
- Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Ankara University, Ankara, Turkiye.
- Division of Clinical Immunology and Allergy, Department of Chest Diseases, Faculty of Medicine, Ankara University, Ankara, Turkiye.
ORCID-Profile: Alper Doğanci, Şebnem Ataman, Ali Erhan Özdemirel, Recep Bülent Seçkin, Ayşe Peyman Yalçin, Sevim Bavbek
Zitieren
APA
Doğanci, A., Ataman, Ş., Özdemirel, A. E., Seçkin, R. B., Yalçin, A. P., & Bavbek, S. (2024). The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis. Turkish Journal of Medical Sciences, 54(6), 1310-1318. https://doi.org/10.55730/1300-0144.5914
Vancouver
Doğanci A, Ataman Ş, Özdemirel AE, Seçkin RB, Yalçin AP, Bavbek S. The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis. Turkish Journal of Medical Sciences. 2024;54(6):1310-1318. doi:10.55730/1300-0144.5914
BibTeX
@article{Doanci2024,
author = {Doğanci, Alper and Ataman, Şebnem and Özdemirel, Ali Erhan and Seçkin, Recep Bülent and Yalçin, Ayşe Peyman and Bavbek, Sevim},
title = {The relationship between drug induced immunogenicity and hypersensitivity reactions and skin tests related to infliximab, etanercept and adalimumab in patients with rheumatoid arthritis and ankylosing spondylitis},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {6},
pages = {1310--1318},
doi = {10.55730/1300-0144.5914}
}
EUVIMED